All right. Thank you, Marcus. Let's now turn our attention to Slide 10, where I'll provide an update on our key initiatives for 2024. Our primary goal this year is to refinance the 2026 senior notes before they go current in January 2025, with a particular focus on reducing debt. We are on track to meet our target of reducing gross debt by $70 million in 2024, supported by business generated free cash flow, a tax refund and proceeds from the recent sale of the softwood lumber duties refund rights. In addition, we are progressing with the sales process of our Paperboard and High-Yield Pulp assets. Interest remains high among the prospective buyers following the announcement of the suspension of operations at the Temiscaming High Purity Cellulose plant, which has introduced some delays due to the change in the underlying assumptions of how the site will be managed. While the suspension and asset sales decisions affecting the Temiscaming site have been approached and carried out independently, we believe that the suspension will bring clarity to the asset sales diligence process by validating that these assets can be effectively run separately. It's important to reemphasize that this is not a fire sale. We have a value threshold based on the high EBITDA margins and the low custodial capital intensity of the Paperboard business. While the proceeds from the sale would obviously reduce our debt load, we are carefully balancing the estimated annual $50 million plus in free cash flow that we receive from these businesses against any potential debt repayment. We plan to complete the transition provided the terms are acceptable before our notes go current in January 2025. We are taking significant steps to optimize our assets and address the ongoing challenges associated with our high-purity cellulose commodity exposure, which has been impacting our profit margins and earnings stability. As part of this strategic pivot, we announced the indefinite suspension of operations at our Temiscaming HPC plant. This decision reflects our commitment to mitigating the financial drag from [ non-soft ] commodities, which projected a 2024 EBITDA loss of $48 million, following a $60 million loss in 2023. I will provide more details on this announcement in the slide that follows. One of the most promising initiatives is the continued expansion of our biomaterials business. Our Tartas Bioethanol plant, our first step of this strategy celebrated its first shipment in April. We anticipate this facility will generate $3 million to $4 million in EBITDA this year with projections of $8 million to $10 million annually from 2025 as we achieved targeted production levels. Looking forward, our biomaterials project pipeline includes the proposed [ AGE ] project at our Jesup facility, which will produce green energy for sale and a new prebiotics additives plant at the same site. We continue to advance the proposed bioethanol plant in Fernandina Beach as we've commenced detailed engineering and submitted the projects air permit with the regulatory authorities. Our proposed projects in the works include crude tall oil operations in both France and the U.S. We aim to finance all these projects with green capital. Let's turn to Slide 11, where I will discuss the recent decision to indefinitely suspend operations at our Temiscaming HPC plant. In April, we made the difficult decision to halt operations at this facility, a move driven by ongoing market weakness in the non fluff commodity markets in uncertain availability of affordable wood fiber and high capital and fixed costs, which when combined altogether, created significant operating losses. The financial implications for 2024 include onetime costs around $30 million for severance, benefits extension, our placement services and mothballing plan. While we are still evaluating noncash impairment charges, we anticipate the overall impact on this year's operating results and adjusted EBITDA to be marginally positive. Furthermore, we expect an improvement in 2024 free cash flow by approximately $15 million to $20 million, driven by the monetization of working capital and reduced CapEx that should more than offset the associated onetime suspension costs. Once mothballed, we believe that this facility will represent the industry's best available oil capacity to satisfy future specialty cellulose demand growth since it will require minimal capital investment to restart, can re-enter supply into the market within a year, exists within an operating industrial site with utilities and other site services and is qualified by many customers to supply CS products. Consequently, we plan to at least annually assess the possibility of restarting the Temiscaming HPC plan. During the suspension period, and after the CS product qualification process concludes, we estimate that we will realize an annualized improvement in adjusted EBITDA of $15 million to $20 million a year, primarily to reduce losses resulting from the HPC commodities sales. We also anticipate an increase of approximately $30 million in free cash flow, $70 million from this EBITDA improvement and the avoidance of custodial capital expenditures. The customer qualification process is actively ongoing with all targeted customers currently testing the CS products from our other plants. This qualification work is expected to take 18 to 24 months. We are building bridge inventory until July to sustain customer demand through this qualification period. The CS business that we expect to retain will be produced from our A and B lines at Jesup and our sulfide plants at Fernandina Beach and Tartas. We remain committed to our fluff business and the majority of our C-line at Jesup will continue to focus on fluff production. Let's turn to Slide 12. We expect enterprise EBITDA to be between $180 million to $200 million for the year. Cash interest expense is projected to add approximately $85 million this year, which includes the $15 million payment that was made in early January for last year's Q4 due to the timing of the interest payment around the holidays. As a reminder, the current normalized annual interest expense is estimated at $70 million. Maintenance CapEx is estimated now at $80 million, reflecting a $5 million reduction due to the suspension of the Temiscaming HPC plant. Additionally, we project a $45 million benefit from working capital, which includes a $30 million increase resulting from the Temiscaming HPC plant suspension. Furthermore, we anticipate $14 million in tax refunds and $39 million from the monetization of the lumber duties, which will be partially offset by impacts related to the Temiscaming HPC plant suspension, deferred energy payments and other accrued liabilities. In summary, we are raising our adjusted free cash flow guidance to a range between $80 million to $100 million for the year. These funds will be allocated toward debt reduction and strategic capital investments. On Slide 13, I dive deeper into the expected 2024 performance of each of our businesses. We project EBITDA for our HPC segment to be in the range of $180 million to $190 million. We anticipate cellulose specialty prices to increase a low single-digit percentage as compared to 2023 as we continue to prioritize value over volume for our specialty products. Sales volumes for cellulose specialties are expected to be comparable to last year, with increases in market share gains resulting from our competitor's plant closure and a modest rise in ethers sales volumes, though ether sales will remain below historical levels. These increases will be partially offset by lower acetate volumes due to modest restocking and a onetime favorable impact from a change in customer contract terms in the prior year. We expect a decline in commodity sales volumes in 2024 due to the planned suspension of operations at our HPC plant in Temiscaming during the second half of the year. Overall costs are anticipated to be lower, driven by improved cost management and production efficiencies alongside the impact from the suspension of operations at the Temiscaming HPC plant. Our growth strategy remains focused on strategic investments in our biomaterials business, capitalizing on the increased demand for sustainable products. The Tartas Bioethanol plant, which was successfully completed its first shipment in April, is operational and projected to contribute $3 million to $4 million in EBITDA in 2024, with expectations to reach $8 million to $10 million at full production by 2025. Regarding Paperboard, we expect to achieve EBITDA in the range of $50 million to $60 million in 2024. Prices are projected to stay consistent with those seen in the first quarter, and we expect sales volumes to increase due to rising customer demand. Raw material prices are expected to increase due to increased purchased pulp prices. We expect our High-Yield Pulp business to achieve EBITDA in the range of $5 million to $10 million in 2024. We expect a slight increase in high-yield pulp prices in Q2 or further rises anticipated in the second half of the year. Additional sales volumes are projected to increase as we move into the second half of 2024. The [ total ] custodial CapEx for the Paperboard and High-Yield Pulp businesses is expected to be $5 million. For 2024, we expect corporate costs of $55 million to $60 million, up slightly versus 2023 as we are the final year of our multiyear ERP implementation. As the ERP project includes, we anticipate cost reductions starting in 2025. It's important to note that these costs may vary due to factors like currency fluctuations, environmental charges and other noncash expenses. On Slide 14, we illustrate the trajectory of our EBITDA margin growth and net leverage decline. In 2024, we anticipate our margins to be in the 11% to 12% range. The forecast for net secured leverage at the end of the year stands at 3x covenant EBITDA. Our commitment remains resolute in achieving our target net debt leverage ratio of 2.5x by 2027. With that, operator, please open the call to questions.